{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T13:10:37Z","timestamp":1792501837934,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":370,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS127391"],"award-info":[{"award-number":["NS127391"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS129188"],"award-info":[{"award-number":["NS129188"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["K23NS099380"],"award-info":[{"award-number":["K23NS099380"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005294","name":"Massachusetts General Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005294","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006694","name":"McLean Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006694","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Stem Cell"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.stem.2025.01.006","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T16:59:08Z","timestamp":1739465948000},"page":"343-360.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Pre-clinical safety and efficacy of human induced pluripotent stem cell-derived products for autologous cell therapy in Parkinson\u2019s disease"],"prefix":"10.1016","volume":"32","author":[{"given":"Jeha","family":"Jeon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yean Ju","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In-Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heejin","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanghyeok","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serhiy","family":"Naumenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minseon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah L.","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zenith","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nayeon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Yoon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HoeWon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seo-Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki-Jun","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Schweitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd M.","family":"Herrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sek Won","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bob","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Leblanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6081-9857","authenticated-orcid":false,"given":"Kwang-Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.stem.2025.01.006_bib1","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson's disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.stem.2025.01.006_bib2","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.stem.2025.01.006_bib3","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.25634.1","article-title":"Recent developments in the treatment of Parkinson's disease","volume":"9","author":"Stoker","year":"2020","journal-title":"F1000Res"},{"key":"10.1016\/j.stem.2025.01.006_bib4","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nrd3430","article-title":"Priorities in Parkinson's disease research","volume":"10","author":"Meissner","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.stem.2025.01.006_bib5","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nm.2165","article-title":"Missing pieces in the Parkinson's disease puzzle","volume":"16","author":"Obeso","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.stem.2025.01.006_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.stem.2025.01.006_bib7","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s13311-011-0069-6","article-title":"Cell therapeutics in Parkinson's disease","volume":"8","author":"Lindvall","year":"2011","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.stem.2025.01.006_bib8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41583-019-0257-7","article-title":"The future of stem cell therapies for Parkinson disease","volume":"21","author":"Parmar","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.stem.2025.01.006_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2018.04.005","article-title":"Pluripotent stem cell-based therapy for Parkinson's disease: current status and future prospects","volume":"168","author":"Sonntag","year":"2018","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.stem.2025.01.006_bib10","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/nrneurol.2015.123","article-title":"Cell-based therapies for Parkinson disease-past insights and future potential","volume":"11","author":"Barker","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.stem.2025.01.006_bib11","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41422-024-00971-y","article-title":"Past, present, and future of cell replacement therapy for Parkinson's disease: a novel emphasis on host immune responses","volume":"34","author":"Park","year":"2024","journal-title":"Cell Res."},{"key":"10.1016\/j.stem.2025.01.006_bib12","first-page":"22","article-title":"Current status and future perspectives on stem cell-based therapies for Parkinson's disease","volume":"16","author":"Cha","year":"2023","journal-title":"J.\u00a0Mov. Disord."},{"key":"10.1016\/j.stem.2025.01.006_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.00729","article-title":"Pluripotent stem cell therapies for Parkinson disease: present challenges and future opportunities","volume":"8","author":"Kim","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.stem.2025.01.006_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2020.00058","article-title":"Advantages and recent developments of autologous cell therapy for Parkinson's disease patients","volume":"14","author":"Osborn","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.stem.2025.01.006_bib15","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1056\/NEJM200103083441002","article-title":"Transplantation of embryonic dopamine neurons for severe Parkinson's disease","volume":"344","author":"Freed","year":"2001","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.stem.2025.01.006_bib16","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.10720","article-title":"A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease","volume":"54","author":"Olanow","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.stem.2025.01.006_bib17","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.stem.2020.09.014","article-title":"Pluripotent stem cell-based cell therapy-promise and challenges","volume":"27","author":"Yamanaka","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.stem.2025.01.006_bib18","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.stem.2025.01.006_bib19","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/ncb3517","article-title":"Metabolic control of primed human pluripotent stem cell fate and function by the miR-200c-SIRT2 axis","volume":"19","author":"Cha","year":"2017","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.stem.2025.01.006_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110155","article-title":"SIRT2 regulates mitochondrial dynamics and reprogramming via MEK1-ERK-DRP1 and AKT1-DRP1 axes","volume":"37","author":"Cha","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.stem.2025.01.006_bib21","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1172\/JCI130767","article-title":"Human autologous iPSC-derived dopaminergic progenitors restore motor function in Parkinson's disease models","volume":"130","author":"Song","year":"2020","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.stem.2025.01.006_bib22","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/s41596-021-00673-4","article-title":"Spotting-based differentiation of functional dopaminergic progenitors from human pluripotent stem cells","volume":"17","author":"Kim","year":"2022","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.stem.2025.01.006_bib23","doi-asserted-by":"crossref","first-page":"E3281","DOI":"10.1073\/pnas.1303669110","article-title":"Inhibition of pluripotent stem cell-derived teratoma formation by small molecules","volume":"110","author":"Lee","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.stem.2025.01.006_bib24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/ons\/opz143","article-title":"Columnar injection for intracerebral cell therapy","volume":"18","author":"Schweitzer","year":"2020","journal-title":"Oper. Neurosurg. (Hagerstown)"},{"key":"10.1016\/j.stem.2025.01.006_bib25","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1056\/NEJMoa1915872","article-title":"Personalized iPSC-derived dopamine progenitor cells for Parkinson's disease","volume":"382","author":"Schweitzer","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.stem.2025.01.006_bib26","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/j.1471-4159.2008.05715.x","article-title":"Notch: from neural development to neurological disorders","volume":"107","author":"Lathia","year":"2008","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.stem.2025.01.006_bib27","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nrn1847","article-title":"Notch signalling in vertebrate neural development","volume":"7","author":"Louvi","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.stem.2025.01.006_bib28","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.stem.2021.01.004","article-title":"Preclinical efficacy and safety of a human embryonic stem cell-derived midbrain dopamine progenitor product, MSK-DA01","volume":"28","author":"Piao","year":"2021","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.stem.2025.01.006_bib29","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1038\/nprot.2017.078","article-title":"Generation of high-purity human ventral midbrain dopaminergic progenitors for in\u00a0vitro maturation and intracerebral transplantation","volume":"12","author":"Nolbrant","year":"2017","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.stem.2025.01.006_bib30","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1089\/scd.2012.0198","article-title":"\u03b3-secretase inhibitors prevent overgrowth of transplanted neural progenitors derived from human-induced pluripotent stem cells","volume":"22","author":"Ogura","year":"2013","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.stem.2025.01.006_bib31","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ydbio.2007.01.001","article-title":"Transient inactivation of Notch signaling synchronizes differentiation of neural progenitor cells","volume":"304","author":"Nelson","year":"2007","journal-title":"Dev. Biol."},{"key":"10.1016\/j.stem.2025.01.006_bib32","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1101\/gr.234443.118","article-title":"Resolving the full spectrum of human genome variation using Linked-Reads","volume":"29","author":"Marks","year":"2019","journal-title":"Genome Res."},{"key":"10.1016\/j.stem.2025.01.006_bib33","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41568-018-0060-1","article-title":"The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers","volume":"18","author":"Sondka","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.stem.2025.01.006_bib34","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s00439-020-02199-3","article-title":"The Human Gene Mutation Database (HGMD((R))): optimizing its use in a clinical diagnostic or research setting","volume":"139","author":"Stenson","year":"2020","journal-title":"Hum. Genet."},{"key":"10.1016\/j.stem.2025.01.006_bib35","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-016-0974-4","article-title":"The Ensembl variant effect predictor","volume":"17","author":"McLaren","year":"2016","journal-title":"Genome Biol."},{"key":"10.1016\/j.stem.2025.01.006_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-17165-w","article-title":"Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson's disease","volume":"11","author":"Doi","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.stem.2025.01.006_bib37","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.stem.2023.08.014","article-title":"Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson's disease, STEM-PD","volume":"30","author":"Kirkeby","year":"2023","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.stem.2025.01.006_bib38","article-title":"Preclinical and dose-ranging assessment of hESC-derived dopaminergic progenitors for a clinical trial on Parkinson's disease","volume":"25\u201338","author":"Park","year":"2024","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.stem.2025.01.006_bib39","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nri2017","article-title":"Humanized mice in translational biomedical research","volume":"7","author":"Shultz","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.stem.2025.01.006_bib40","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-022-03104-7","article-title":"Single-cell transcriptomics reveals the cell fate transitions of human dopaminergic progenitors derived from hESCs","volume":"13","author":"Liang","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.stem.2025.01.006_bib41","article-title":"Single cell transcriptomics identifies stem cell-derived graft composition in a model of Parkinson's disease","volume":"11","author":"Tiklov\u00e1","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.stem.2025.01.006_bib42","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.stem.2021.03.010","article-title":"A step closer to autologous cell therapy for Parkinson's disease","volume":"28","author":"Schweitzer","year":"2021","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.stem.2025.01.006_bib43","doi-asserted-by":"crossref","first-page":"859","DOI":"10.2217\/rme-2018-0095","article-title":"Quality control guidelines for clinical-grade human induced pluripotent stem cell lines","volume":"13","author":"Sullivan","year":"2018","journal-title":"Regen. Med."},{"key":"10.1016\/j.stem.2025.01.006_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/srep17258","article-title":"The molecular karyotype of 25 clinical-grade human embryonic stem cell lines","volume":"5","author":"Canham","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.stem.2025.01.006_bib45","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nature22312","article-title":"Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations","volume":"545","author":"Merkle","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.stem.2025.01.006_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/nrm.2017.52","article-title":"Stem cells: stem cell-based therapies threatened by the accumulation of p53 mutations","volume":"18","author":"Baumann","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.stem.2025.01.006_bib47","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1056\/NEJMcibr1706906","article-title":"Potential pitfall of pluripotent stem cells","volume":"377","author":"Trounson","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.stem.2025.01.006_bib48","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/neuonc\/nou087","article-title":"The epidemiology of glioma in adults: a \"state of the science\" review","volume":"16","author":"Ostrom","year":"2014","journal-title":"Neuro. Oncol"},{"key":"10.1016\/j.stem.2025.01.006_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004432","article-title":"Genetic background drives transcriptional variation in human induced pluripotent stem cells","volume":"10","author":"Rouhani","year":"2014","journal-title":"PLoS Genet."},{"key":"10.1016\/j.stem.2025.01.006_bib50","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.stemcr.2015.12.009","article-title":"Genetic variability overrides the impact of parental cell type and determines iPSC differentiation potential","volume":"6","author":"Kytt\u00e4l\u00e4","year":"2016","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.stem.2025.01.006_bib51","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nbt.3388","article-title":"A comparison of genetically matched cell lines reveals the equivalence of human iPSCs and ESCs","volume":"33","author":"Choi","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.stem.2025.01.006_bib52","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/s41586-023-06300-4","article-title":"Co-transplantation of autologous T(reg) cells in a cell therapy for Parkinson's disease","volume":"619","author":"Park","year":"2023","journal-title":"Nature"}],"container-title":["Cell Stem Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1934590925000062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1934590925000062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T14:50:24Z","timestamp":1772895024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1934590925000062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1934590925000062"],"URL":"https:\/\/doi.org\/10.1016\/j.stem.2025.01.006","relation":{},"ISSN":["1934-5909"],"issn-type":[{"value":"1934-5909","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pre-clinical safety and efficacy of human induced pluripotent stem cell-derived products for autologous cell therapy in Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Cell Stem Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.stem.2025.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}